Ramelteon Tablet
Product Images NDC 76420-628

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 76420-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Label)

Label for Ramelteon Tablets 8 mg by Asclemed USA, Inc., relabeled by Enovachem Pharmaceuticals. The label includes the NDC 76420-628-01, quantity of 100 tablets, and distribution info from Zydus Pharmaceuticals (USA) Inc. It contains storage instructions and a federal law caution for prescription dispensing.*

FDA Label Image

Image (Structure)

Chemical structure of Ramelteon, showing its molecular composition and arrangement including an indole-like fused ring system with a tetrahydrofuran substituent and an ethyl carbamoyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.